All Type of News


Rude multinational companies, causing defect & out-of-stock issues

Even if it has happened for a while, a lot of complaints have still been created on multinational pharmaceutical companies’ high-handed behaviors. The pharmaceutical circles raised voices that there has been no promp...

National Pension Service makes losses over Hanmi Pharm’s delayed notification

Assemblyperson Seok-Jin Kang from the Saenuri Party raised a possibility of unfair trade regarding losses on selling Hanmi Pharm’s short stocks. At the National Assembly for the National Pension Service on the 10th, ...

“NPS should file for damage claims if finding Hanmi’s illegal activities”

While the Hanmi Pharm’s delayed report about patient side effects has aroused various doubts, a suggestion was made if the National Pension Service should file a damage claim for estimated losses of KRW 150 billion on...

Ildong Pharmaceutical selected for probiotics-related national projects

Ildong Pharmaceutical(CEO Woong-Sup Yoon) was selected for national projects related to probiotics by the government. Ildong Pharmaceutical announced it will exercise the Minis...

What are reasons why Pfizer spend energies on ‘Centrum’ marketing?

Recently, Pfizer Pharmaceuticals Korea has given its best on promoting the top 2nd product in the Korean vitamins market, ‘Centrum.’ It means the company will target OTC drugs a...

Which are multinational pharmas actively making joint researches with Korea?

Which are multinational pharmaceutical companies that are active on joint researches and developments with Korean medical institutes and hospitals? According to the KRPIA Research Report published by the Korean Resea...

Pharmaceutical wholesalers to enlarge new dist. channels with convenience and H&B stores

Pharmaceutical distribution companies started to focus on building new distribution channels to strengthen values of products they distribute. According to the distribution industry, sales of emergency household drug...

Multinational pharma raises controversy over obligation of

Pharmaceutical distribution companies raise complaints over a multinational company which has established agreements with unfair terms and conditions, such as obligation of ordering inventories for 3 months. Unlike ...

Listed pharmas’ stock prices dropped by 17% after Hanmi incident

Stock prices of listed pharmaceutical companies collapsed by 17% after the Hanmi Pharm crisis. Moreover, approximately KRW 9 trillion was studied to evaporate from these listed pharmas’ market capitalization by the ...

Hanmi, “Olmutinib in progress, Phase 3 plan temporarily suspended”

When it comes to the ‘the300’s(Money Today)’ article ‘Boehringer already suspended clinical trial this August… did it really not know about it,’ Hanmi Pharm announced on the 7th...

Most Read News


March
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
23
24
25
26
27
28
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.